UPCOMING WEBINAR

Upcoming Webinar

SBRT for Primary Spine Tumors

April 9, 2026, 12:00pm Eastern Time

Presented by:

  • Anubhav G. Amin, MD
  • Molly H. Blau, MD, MS
  • Kristin Redmond, MD, MPH
  • Moderator: Fatemeh Fekrmandi, MD, MSc

Description and Objectives:

Webinar Description: 

In this webinar, we will discuss the emerging role of SBRT in the management of primary spinal tumors chordoma and benign spine tumors including hemagioma and schwannoma. We will also be discussing the role of SBRT in the management of vertebral body hemangiomas and intradural benign tumors.


Educational Objectives: 

Discuss the role of SBRT in the management of spine and sacral chordoma

Discuss target delineation for SBRT for spine and sacral chordoma

Discuss the role of SBRT in the management of benign spine tumors including hemangioma and schwannoma

  • Discuss the role of SBRT in the management of vertebral body hemangiomas.
  • Discuss the role of SBRT in the management of intradural benign tumors.

Satisfactory Completion

  • Learners must complete an online evaluation form within 45-days of live webinar to receive a certificate of completion.
  • You must attend the entire webinar as partial credit is not available.
  • If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Statement of Need

Advances in the applications, technologies and methodologies of stereotactic radiosurgery/stereotactic body radiation therapy (SRS/SBRT) continue to evolve rapidly and the delivery of treatment has become more complex, making it imperative that oncology professionals remain current in the state-of-the-art techniques. The Radiosurgery Society is committed to providing educational programming that creates a forum for global collaboration to improve professional practice by increasing their level of knowledge, as required to improve competency in the field of oncology.

Target Audience

The target audience includes radiation oncologists, surgeons, medical physicists, nurses, residents, trainees and healthcare providers in the field of SRS/SBRT, radiation oncology and medical oncology.

Accreditation Statements

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The Radiosurgery Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

Amedco LLC designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

  • Anubhav G. Amin, MD - Globus:Consultant
  • Molly H. Blau, MD, MS - NA
  • Kristin Redmond, MD, MPH - Elekta AB, icotec, Canon:Research Grant Site Principal Investigator Accuray, Telefl ex, Gamma tile:Research Grant Overall Principal Investigator BioMimetix:Scientifi c/Medical Advisory Board Member Brainlab:travel expenses
  • Moderator: Fatemeh Fekrmandi, MD, MSc - NA

Acknowledgement of Financial Commercial Support

<em>No financial commercial support was received for this educational activity.</em>

Acknowledgement of In-Kind Commercial Support

<em>No in-kind commercial support was received for this educational activity.</em>

Certificate of Participation

If continuing education credits are applicable for this webinar, a certificate will be issued upon completion of course requirements, including the online evaluation, enabling you to register your credit with the appropriate licensing boards or associations. Evaluations must be completed within 45 days of live webinar.

Please contact webinars@therss.org if you have questions.